"Characterization of the Class I-Restricted gp100 Melanoma Peptide-stimulated Primary Immune Response in Tumor-Free Vaccine-draining Lymph Nodes and Peripheral Blood" by Edwin B. Walker

Selected Works of Walter J. Urba, MD, PhD

Article

Characterization of the Class I-Restricted gp100 Melanoma Peptide-stimulated Primary Immune Response in Tumor-Free Vaccine-draining Lymph Nodes and Peripheral Blood

Clinical Cancer Research (2009)

Edwin B. Walker, Providence Portland Medical Center
William Miller, Northwestern University
Daniel Haley, Providence Regional Medical Center Everett
Kevin Floyd, Providence Portland Medical Center
Brendan Curti, Providence Portland Medical Center
Walter J. Urba, Providence Portland Medical Center

Link

Disciplines

Publication Date

March 10, 2009

DOI

10.1158/1078-0432.CCR-08-2806

Citation Information

Edwin B. Walker, William Miller, Daniel Haley, Kevin Floyd, et al.. "Characterization of the Class I-Restricted gp100 Melanoma Peptide-stimulated Primary Immune Response in Tumor-Free Vaccine-draining Lymph Nodes and Peripheral Blood" Clinical Cancer Research Vol. 15 Iss. 7 (2009) p. 2541 - 2551
Available at: http://works.bepress.com/walter-urba/178/